申请人:SEQUOIA PHARMACEUTICALS, INC.
公开号:US20170354636A1
公开(公告)日:2017-12-14
Compositions and methods are provided for improving the treatment of tumors by inhibiting cytochrome P450 enzymes (“CYPs”) expressed by tumors. Inhibition of tumor-expressed CYPs provides improved dosing of anti-tumor drugs, inhibits development of drug resistance by tumors and provides improved patient outcomes.